EVO

Evotec SE EVO

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 34 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$788.37M

Quarter to Dec 31

Net income

$-103.52M

Quarter to Dec 31

Free cash flow

$-81.72M

Quarter to Dec 31

Operating margin

-7.1%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$9.07M total
DCF Advisers, LLC
$3.02M+1.3%
WCM INVESTMENT MANAGEMENT, LLC
$1.88M+7.1%
ABC ARBITRAGE SA
$1.04M-26.9%
Optiver Holding B.V.
$902.0K+13.6%
MORGAN STANLEY
$576.1K-20.8%
LPL Financial LLC
$464.9K+35.7%
ENVESTNET ASSET MANAGEMENT INC
$390.9K+16.9%
OLD MISSION CAPITAL LLC
$106.5K+96.6%
Pathstone Holdings, LLC
$100.2K+4.8%
Fore Capital, LLC
$87.8K0.0%
Snowden Capital Advisors LLC
$71.1K+4.0%
MILLENNIUM MANAGEMENT LLC
$63.9K-77.1%
XTX Topco Ltd
$50.1K-9.4%
CAPTRUST FINANCIAL ADVISORS
$41.3KNew
Vanguard Personalized Indexing Management, LLC
$38.1K-32.4%
BNP PARIBAS FINANCIAL MARKETS
$37.2K-13.1%
Apollon Wealth Management, LLC
$34.2K+9.5%
CSS LLC/IL
$33.9K0.0%
GEODE CAPITAL MANAGEMENT, LLC
$31.6KNew
Rockefeller Capital Management L.P.
$28.6K0.0%
Concurrent Investment Advisors, LLC
$28.0K0.0%
UMB Bank, n.a.
$23.0K+14.2%
Global Retirement Partners, LLC
$12.3K--
Smartleaf Asset Management LLC
$3.7K0.0%
PRIVATE TRUST CO NA
$1.4K0.0%
See all 34 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

EVO key financials by period

Reported revenue, net income and operating margin by fiscal year, from Evotec SE's annual filings on SEC EDGAR.

Evotec SE reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$788.4M$-103.5M-7.1%
FY 2024$797.0M$-196.1M-17.9%
FY 2023$781.4M$-83.9M-6.1%
FY 2022$751.4M$-175.7M2.8%
FY 2021$618.0M$215.5M6.6%
FY 2020$500.9M$6.3M9.7%
Source: EVO filings on SEC EDGAR →

About Evotec SE (EVO): stock profile, AI score and financials

Evotec SE (EVO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. EVO is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 34 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), Evotec SE reports quarterly revenue of $788.4M, net income of $-103.5M, an operating margin of -7.1%. Top institutional holders of EVO by reported 13-F value include DCF Advisers, WCM INVESTMENT MANAGEMENT, ABC ARBITRAGE SA, based on the most recent SEC filings. EVO trades on the Nasdaq exchange and files with the SEC under CIK 1412558. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EVO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Evotec SE directly from SEC EDGAR.

SEC EDGAR: CIK 1412558 →